ABSTRACT
Objetivo : Determinar el impacto del aseguramiento en salud en la economía de los hogares peruanos en el periodo 2010-2019. Materiales y Métodos : Estudio analítico transversal, que utilizó la base de datos de la Encuesta Nacional de Hogares de los años 2010, 2014 y 2019 para analizar el impacto del aseguramiento en salud en términos de gasto de bolsillo en salud, gasto catastrófico y empobrecimiento de los hogares peruanos, así como determinar qué otros factores se encuentran asociados. Resultados : Durante el periodo de estudio se observó que los hogares peruanos presentaron una disminución del gasto de bolsillo en salud promedio mensual (S/.119,9 en 2010 a S/.107,9 en 2019), así como del porcentaje de hogares con gasto catastrófico en salud (4,06 % en 2010 a 3,47 % en 2019) y del porcentaje de hogares que empobrecen por gastos de bolsillo en salud (1,78 % en 2010 a 1,51 % en 2019). Los factores asociados al gasto catastrófico en salud y al empobrecimiento fueron el menor nivel de escolaridad del jefe del hogar, la presencia de miembros con enfermedad crónica y el área de residencia rural. La ausencia de aseguramiento en salud se asoció significativamente a un mayor riesgo de gasto de bolsillo en salud catastrófico, mas no al empobrecimiento. Conclusiones : El aumento de la cobertura de aseguramiento en salud contribuye a la protección financiera de los hogares peruanos frente al gasto de bolsillo en salud; sin embargo, las barreras para el acceso efectivo a los servicios de salud y otros factores socioeconómicos pueden limitar significativamente su impacto.
Objective : To determine the impact of health insurance in the economy of Peruvian households during the 2010-2019 period. Material and Methods : This is a cross-sectional analytical study that used the database of the National Peruvian Household Surveys from years 2010, 2014, and 2019, aiming to analyze the impact of health insurance in terms of pocket money spending for health issues, catastrophic healthcare spending, and impoverishment in Peruvian households, and also to determine the presence of other associated factors. Results : During the study period, it was observed that Peruvian households reduced their monthly average pocket money spending for health issues (119.9 PEN in 2010 and 107.9 PEN in 2029), as well as the percentage of household with catastrophic healthcare expenses (4.06% in 2010 to 3.47% in 2019), and the percentage of households who became impoverished because of pocket money expenses for health issues (1.78% in 2020 to 1.51% in 2019). Factors associated to catastrophic healthcare expenses and to impoverishment were lower educational level for the household leader, the presence of family members with chronic diseases, and living in a rural area. The absence of health insurance was significantly associated to a greater risk for catastrophic healthcare expenses, but not to impoverishment. Conclusions : Increased healthcare insurance coverage contributes to financial protection of Peruvian households against pocket money spending for health issues; however, barriers for effective access to healthcare services, and other socioeconomical factors may significantly limit this impact.
ABSTRACT
With the reform of organ donation and transplantation in China, the establishment of Organ Procurement Organization (OPO) will become more centralized and enlarged in scale, evolving into the united OPO development stage coordinated by multiple hospitals. How to enhance the operation management and scientific development planning of united OPO has become an urgent and novel issue facing the administrators at all levels. At present, certain constraint factors of united OPO still exist in the integrated management, cost control, service homogenization, cultural integration and discipline layout. To give full play to the large-scale benefits and expand the supply of high-quality organ donation services, the development principle of putting connotation construction first and the appropriate direction of public welfare should be upheld. Leading and driving the development of organ donation services of our province are the responsibility, and discipline construction and talent training serve as the core. The overall development plan should be determined in a scientific pattern and homogeneous management should be implemented according to local conditions, aiming to provide successful experience for establishing a provincial unified OPO.
ABSTRACT
OBJECTIVE To evaluate th e effects of comprehensive drug cost control in China ，and to provide reference for further improving the effects of cost control. METHODS Entropy method was used to establish a comprehensive evaluation index system of the comprehensive drug cost control effect from the respective of drug price control ability ，drug cost control ability and patient affordability. The comprehensively evaluate the effects of drug cost control in 31 provinces （autonomous regions and municipalities）during 2016-2020. The k-means cluster method was used to analyze the effects of comprehensive drug cost control in various provinces. RESULTS & CONCLUSIONS During the period of 2016-2020，the total score of comprehensive drug cost control effect of 31 provinces were 14.64，16.71，17.58，17.57，17.88，respectively. The results of cluster analysis were similar to the ranking of entropy method. Medical and health system reform policy had entered a stable period after achieving phased results ； the effects of comprehensive drug cost control was characterized by regional steps in 31 provinces；the effects of comprehensive drug cost control were better in developed coastal areas and some provinces and cities of western regions ，followed by provinces and cities in central China ；however，comprehensive drug cost control in 3 provinces of northeast China showed poor effect. The effects of comprehensive drug cost control in pilot cities of comprehensive medical reform were significantly improved. It is suggested that the successful experience of pilot cities of comprehensive medical reform should be promoted nationwide ，and policies such as volume-based drug procurement ，medical insurance drug price negotiation ，and diagnosis-related groups / diagnosis-intervention packet payment method reform should be further deepened.
ABSTRACT
ABSTRACT Objective: To analyze the average direct costs of outpatient, hospital, and home care provided to patients with chronic wounds. Method: Quantitative, exploratory-descriptive case study, carried out in a Comprehensive Wound Care Unit. Costs were obtained by multiplying the time spent by professionals by the unit cost of labor in the respective category, adding to the costs of materials and topical therapies. Results: Outpatient care costs corresponded to US$4.25 (SD ± 7.60), hospital care to US$3.87 (SD ± 17.27), and home care to US$3.47 (SD ± 5.73). In these three modalities, direct costs with dressings and medical consultations were the most representative: US$7.76 (SD ± 9.46) and US$6.61 (SD ± 6.54); US$7.06 (SD ± 24.16) and US$15.60 (SD ± 0.00); US$4.09 (SD ± 5.28) and US$15.60 (SD ± 0.00), respectively. Conclusion: Considering comprehensive care for patients with chronic wounds, the mean total direct cost was US$10.28 (SD ± 17.21), with the outpatient modality being the most representative in its composition. There was a statistically significant difference (p value = 0.000) between the costs of home and outpatient, home and hospital, and outpatient and hospital care.
RESUMEN Objetivo: Analizar los costos directos promedios de la atención ambulatoria, hospitalaria y domiciliaria prestada a pacientes con heridas crónicas. Método: Investigación cuantitativa, exploratoria-descriptiva, del tipo estudio de caso, realizada en una Unidad de Atención Integral de Heridas. Los costos se obtuvieron al multiplicar el tiempo dedicado por los profesionales por el costo unitario de la mano de obra en la respectiva categoría, sumado a los costos de materiales y terapias tópicas. Resultados: Los costos de atención ambulatoria correspondieron a US$ 4,25 (DE ± 7,60), hospitalaria a US$ 3,87 (DE ± 17,27) y atención domiciliaria a US$ 3,47 (DE ± 5,73). En estas tres modalidades, los costos directos con apósitos y consultas médicas fueron los más representativos: US$7,76 (DE ± 9,46) y US$6,61 (DE ± 6,54); US$7,06 (DE ± 24,16) y US$15,60 (DE ± 0,00); US$4,09 (DE ± 5,28) y US$15,60 (DE ± 0,00), respectivamente. Conclusión: Considerando la atención integral a pacientes con heridas crónicas, el costo directo promedio total fue de US$ 10,28 (DE ± 17,21), siendo la modalidad ambulatoria la más representativa en su composición. Hubo una diferencia estadísticamente significativa (p-valor = 0,000) entre los costos de atención domiciliaria y ambulatoria; domiciliaria y hospitalaria y, por fin, ambulatoria y hospitalaria.
RESUMO Objetivo: Analisar os custos diretos médios da assistência ambulatorial, hospitalar e domiciliar prestada aos pacientes com feridas crônicas. Método: Pesquisa quantitativa, exploratório-descritiva, do tipo estudo de caso, realizada numa Unidade de Tratamento Integral de Ferida. Obtiveram-se os custos multiplicando-se o tempo despendido pelos profissionais pelo custo unitário da mão de obra da respectiva categoria, somando-se aos custos dos materiais e terapias tópicas. Resultados: Os custos da assistência ambulatorial corresponderam a US$4,25 (DP ± 7,60), da hospitalar a US$3,87 (DP ± 17,27) e da domiciliar a US$3,47 (DP ± 5,73). Nessas três modalidades, os custos diretos com os curativos e consultas médicas foram os mais representativos: US$7,76 (DP ± 9,46) e US$6,61 (DP ± 6,54); US$7,06 (DP ± 24,16) e US$15,60 (DP ± 0,00); US$4,09 (DP ± 5,28) e US$15,60 (DP ± 0,00), respectivamente. Conclusão Considerando a assistência integral aos pacientes com feridas crônicas, o custo direto médio total foi de US$10,28 (DP ± 17,21), sendo a modalidade ambulatorial a mais representativa na sua composição. Constatou-se diferença estatística significante (valor p = 0,000) entre os custos da assistência domiciliar e ambulatorial, domiciliar e hospitalar e ambulatorial e hospitalar.
Subject(s)
Direct Service Costs , Nursing , Costs and Cost Analysis , Wounds and Injuries , Health Care Costs , Cost ControlABSTRACT
Objective:To analyze the composition, the changes of expense structure and the influencing factors of hospitalization expenses, for reference in optimizing the cost control of day surgery.Methods:Collection of the first page data of patients with the top three diseases(varicose veins of lower limbs, chronic cholecystitis and varicocele)in the day surgery volume ranking in three tertiary general hospitals in a city in 2020. The confounding factors were eliminated through propensity matching. The structural change of hospitalization expenses was analyzed by structural change degree, and the influencing factors of hospitalization expenses were analyzed by grey correlation degree and multiple linear regression.Results:After 1∶1 propensity matching of the first page data of 752 patients with day surgery and non day surgery, 98 patients with lower extremity varicose veins, 356 patients with chronic cholecystitis and 38 patients with varicocele were finally included. Compared with non day hand, the total hospitalization cost of day surgical instruments decreased, and the cost structure changes of chronic cholecystitis, varicocele and varicose veins of lower limbs were 14.59%, 6.20% and 16.20% respectively. Among them, the general medical service fee, nursing fee and examination and laboratory fee showed a downward trend, and the fees of materials and drugs showed an upward trend. General medical service fee, nursing fee, examination and laboratory fee, clinical diagnosis fee, treatment fee, drug fee, material fee and other expenses presented a high correlation with the cost of day surgery(grey correlation>0.90). The payment method, wound healing type and discharge diagnosis can influence the cost of day surgery( P<0.05). Conclusions:Compared with non daytime surgery, the total hospitalization cost of day surgery has a certain cost control effect, but it can not reduce the cost of all projects. The main influencing factors are the internal composition of the cost, payment method and so on. The hospitals should focus on tapping the internal cost control potential of day surgery and further expanding the coverage of day surgery diseases.
ABSTRACT
Objective:To analyze the impact of Beijing Medical Reform on inpatient costs of medical and surgical patients in a hospital, and to provide reference for the hospital to explore the path of patient cost control.Methods:Based on the data of medical and surgical inpatients′ expenses from June 2016 to December 2019 in a hospital in Beijing, breakpoint regression method was used to analyze the impact of the two reforms(namely the comprehensive reform of separation of medicine and pharmacy and the comprehensive reform of medical consumption linkage)on the level of medical and surgical inpatients′ expenses and the cost structure of drugs and consumables.Results:The two reforms controlled the rapid rise of hospitalization expenses and reduced the proportion of drugs and medical consumption. The effect of the reforms on the total cost control of internal medical patients was better than that of surgical patients.For internal medical patients, the reform of separation of medicine and pharmacy played a greater role in the proportion of medicine; For surgical patients, the two reforms had effectively reduced the proportion of consumables, and the proportion of drugs had gradually decreased.Conclusions:The two reforms have effectively controlled the growth trend of hospitalization expenses, and changed the cost structure of drugs and consumables.
ABSTRACT
ABSTRACT Objective: To analyze the percentage of the coverage of transfers from the Brazilian Unified Health System regarding nursing procedures conducted in the Outpatient facility of a University Hospital. Method: Quantitative, exploratory, descriptive case study. The sample for calculating the mean total direct costs was composed of non-participant observations of 656 procedures. The obtained costs were compared to transfers from the Unified Health System by multiplying the amount of procedures agreed upon by the unit cost in the Unified Table of Procedures in 2016 and 2017. Results: The Unified Health System transferred a percentage corresponding to 11.13% of the actual cost in 2016 and to 16.02% in 2017. In these two years, transfer values covered only a mean of 13.4%, resulting in a percentage difference in revenue significantly smaller than the actual cost. Conclusion: The higher the productivity of the performed procedures, the higher was the hospital deficit and, consequently, the higher were the costs not covered by the Unified Health System.
RESUMEN Objetivo: Analizar el porcentaje de cobertura de las transferencias del Sistema Único de Salud relacionadas con los procedimientos de enfermería realizados en el Ambulatorio de un Hospital Universitario. Método: Investigación cuantitativa, exploratoria-descriptiva y de tipo estudio de caso. La muestra para el cálculo del total de los promedios de los costos directos consistió en la observación no participativa de 656 procedimientos. Los costos obtenidos se compararon con la transferencia del Sistema Único de Salud multiplicando el número de procedimientos acordados por el costo unitario en la Tabla Unificada de Procedimientos en los años 2016 y 2017. Resultados: El Sistema Único de Salud transmitió un porcentaje correspondiente al 11,13% del costo real en 2016 y al 16,02% en 2017. En esos dos años, los valores de transferencia abarcaron, en promedio, sólo el 13,4%, lo que dio lugar a una diferencia porcentual en los ingresos significativamente inferior a los costos reales. Conclusión: Cuanto mayor fue la productividad de los procedimientos realizados, mayor fue el déficit para el Hospital y, en consecuencia, mayores fueron los costos no cubiertos por el Sistema Único de Salud.
RESUMO Objetivo: Analisar o percentual de cobertura do repasse do Sistema Único de Saúde relativo aos procedimentos de enfermagem realizados no Ambulatório de um Hospital Universitário. Método: Pesquisa quantitativa, exploratório-descritiva, do tipo estudo de caso. A amostra para o cálculo dos custos médios totais diretos constituiu-se da observação não participante de 656 procedimentos. Os custos obtidos foram comparados com o repasse do Sistema Único de Saúde multiplicando-se a quantidade de procedimentos pactuados pelo custo unitário da Tabela de Procedimentos Unificada nos anos de 2016 e 2017. Resultados: O Sistema Único de Saúde repassou percentagem correspondente a 11,13% do custo real em 2016 e a 16,02 % em 2017. Nesses dois anos, os valores de repasse cobriram, em média, apenas 13,4%, resultando numa diferença percentual de receita significantemente inferior aos custos reais. Conclusão: Quanto maior a produtividade dos procedimentos realizados, maior foi o déficit para o Hospital e, consequentemente, maiores foram os custos não cobertos pelo Sistema Único de Saúde.
Subject(s)
Unified Health System , Health Care Costs , Costs and Cost Analysis , Cost Control , Ambulatory Care , Nursing CareABSTRACT
Objective:To study the reasons of excessive expenses in hospital and explore the segmented management of the cost of DRG group.Methods:Taking the FC35(coronary artery bypass grafting, without complications and comorbidities)as an example, 1 416 patients of FC35 group discharged from the hospital from June to December 2019 were selected. Taking the average cost of the disease group in the tertiary general hospitals of Beijing in 2019 as the benchmark value, the patients were divided into patients with excessive cost and patients without excessive cost. The hospitalization expenses of the two groups were compared and analyzed, the horizontal comparison between departments and the segmented statistics of patients′ expenses were conducted.Results:In the FC35 group, 614 patients(43.36%)had excessive hospitalization costs. Clinical departments B, D and E had the largest number of cases and the overall cost efficiency was better. Operating room and anesthesiology expenses accounted for 52.77% of the total cost of patients. The cost of high-value tube, high-value line, high-value other, mesh and sanitary materials in the operating room ranked in the top 5.Conclusions:The cost of high value consumables in the operating room is one of the important reasons for the excessive cost of patients.
ABSTRACT
OBJECTIVE：To study the cost control measures for Medicaid prescription drugs in the United States ，and to provide reference for medical insurance cost control in China. METHODS ：The policy documents ，academic papers and news reports were studied to comb the practice of drug cost control policy of Medicaid project in the United States and its impact on medical insurance costs. The suggestions were put forward for medical insurance cost control in China. RESULTS & CONCLUSIONS：The cost control measures of Medicaid prescription drugs adopted in the United States include drug utilization management and drug cost control measure. The former included the list of preferred drugs ，pre-authorization and step therapy ， prescription cost limit ，while the latter included the upper limit control of drug expenditure growth ，closed drug list management ， etc. The list of preferred drugs is the basis of a series of drug cost control measures ，which provides a policy framework for prior authorization and step therapy ；pre-authorization and step therapy are the specific ways to controlling the cost ，and the use of low-cost drugs is encouraged through the guidance of specific cases ；the prescription cost limit starts from controlling the drug cost of a single patient and saves the medical insurance expenditure from another angle ；the drug growth caps control is controlling the total cost of medical insurance expenditure from aspect of overall cost ，which is a supplement to the traditional method ；closed drug list management is a new policy attempt to break through the limitation of preferred drug list. The prescription drug cost control measures adopted by Medicaid project can effectively reduce the drug expenditure to a certain extent ，but it also has the possibility of harming the interests of patients because it can interfere with doctors ’prescription right. China should further strengthen the role of medical insurance in the medical service system ，and carefully learn from the management measures of Medicaid drug utilization in the United States ；improve the dynamic control mechanism of medical insurance expenditure ，take special measures for key drugs ； improve the drug list management mechanism ，pay attention to the three links of access， exit and dynamic adjustment ， guide medical cn institutions to use drugs rationally.
ABSTRACT
RESUMO Objetivo: Identificar o custo direto médio dos procedimentos realizados para o tratamento do evento adverso flebite em pacientes de uma Unidade de Internação Clínica e estimar o custo dos procedimentos realizados para o tratamento das flebites nesta unidade. Método: Pesquisa quantitativa, exploratório-descritiva, do tipo estudo de caso único. Inicialmente, identificaram-se os registros dos procedimentos realizados para o manejo das flebites em 2017. Em seguida, o custo foi calculado multiplicando o tempo (cronometrado) despendido por técnicos de enfermagem pelo custo unitário da mão de obra direta, somando-o ao custo dos materiais. Resultados: Foram notificadas 107 flebites referentes a 96 pacientes. No tratamento dos diferentes graus de flebite, realizaram-se três procedimentos "aplicação de pomada de extrato de flor de camomila"; "aplicação de compressas"; "instalação de acesso venoso periférico". A "instalação de acesso venoso periférico com cateter Íntima®" correspondeu ao procedimento mais oneroso (US$ 8,90-DP=0,06). Considerando o registro da execução de 656 (100%) procedimentos, a estimativa do custo direto médio total correspondeu a US$ 866,18/ano. Conclusão: O conhecimento sobre os custos dos procedimentos pode subsidiar tomadas de decisão que incrementem a alocação eficiente dos recursos consumidos.
RESUMEN Objetivo: Identificar el costo directo promedio de los procedimientos realizados para el tratamiento del evento adverso de flebitis en pacientes de una Unidad de Hospitalización Clínica y estimar el costo de los procedimientos realizados para el tratamiento de flebitis en esta unidad. Método: Cuantitativo, exploratorio-descriptivo, tipo de estudio de caso único. Inicialmente, en 2017, se identificaron los registros de los procedimientos realizados para el tratamiento de la flebitis. Luego, el costo se calculó multiplicando el tiempo (cronometrado) gastado por los técnicos de enfermería por el costo unitario de la mano de obra directa, agregándolo al costo de los materiales. Resultados: Se informaron 107 flebitis referidas a 96 pacientes. En el tratamiento de los diferentes grados de flebitis, se llevaron a cabo tres procedimientos: "aplicación de ungüento de extracto de flor de manzanilla"; "Aplicación de compresas"; "Instalación de acceso venoso periférico". La "instalación de acceso venoso periférico con un catéter Íntima®" correspondió al procedimiento más costoso (US$ 8.90-SD=0.06). Considerando el registro de la ejecución de 656 (100%) procedimientos, la estimación del costo directo promedio total correspondió a US$ 866.18/año. Conclusión: El conocimiento sobre los costos de los procedimientos puede respaldar la toma de decisiones que aumenta la asignación eficiente de los recursos consumidos.
ABSTRACT Objective: To identify the average direct cost of the procedures performed for phlebitis treatment in patients in an Inpatient Unit and estimate the costs of the procedures performed to treat phlebitis in this unit. Method: A quantitative, exploratory-descriptive, single-case study. Initially, records of the procedures performed for phlebitis management were identified. Then, the cost was calculated by multiplying the execution time (timed using a chronometer) spent by nursing technicians by the unit cost of direct labor, added to the cost of materials in 2017. Results: 107 phlebitis referring to 96 patients were reported. To treat the different grades of phlebitis, three procedures were carried out "application of ointment of chamomile flower extract"; "Compress application"; "Peripheral venous access installation". "Peripheral venous access installation with Íntima® catheter" corresponded to the most expensive procedure (US$ 8.90-SD=0.06). Considering the record of the execution of 656 (100%) procedures, the total average direct cost estimate corresponded to US$ 866.18/year. Conclusion: Knowledge about the costs of procedures can support decision making that increase allocation efficiency of consumed resources.
Subject(s)
Humans , Phlebitis/economics , Catheterization, Peripheral/economics , Inpatients , Cost Control , Costs and Cost Analysis , Nursing CareABSTRACT
ABSTRACT Objectives: to analyze the mean direct cost and peripheral venous access length outcomes using devices over needle with and without extension. Methods: quantitative, exploratory-descriptive research. Venous punctures and length of the devices were followed. The mean direct cost was calculated by multiplying the time (timed) spent by nursing professionals by the unit cost of labor, adding to the cost of materials. Results: the total mean direct cost of using devices "with extension" (US$ 9.37) was 2.9 times the cost of using devices "without extension" (US$ 4.50), US$ 7.71 and US$ 2.66, respectively. Totaling 96 hours of stay, the "device over needle with extension" showed a lower occurrence of accidental loss. Conclusions: the use of the "device over needle with extension", despite its higher mean direct cost, was more effective in favoring adequate length of peripheral venous access.
RESUMEN Objetivos: analizar el costo directo promedio y los resultados de permanencia del acceso venoso periférico, utilizando dispositivos de aguja con y sin extensión. Métodos: investigación cuantitativa, exploratoria descriptiva. Se siguieron los pinchazos venosos y el tiempo de permanencia de los dispositivos. El costo directo promedio se calculó multiplicando el tiempo (cronometrado) dedicado por los profesionales de enfermería por el costo unitario de la mano de obra, lo que se suma al costo de los materiales. Resultados: el costo directo promedio total de usar dispositivos "extendidos" (US$ 9,37) fue 2,9 veces el costo de usar dispositivos "no extendidos" (US$ 4,50) de materiales, US$ 7.71 y US$ 2.66, respectivamente. Con un total de 96 horas de estadía, el "dispositivo de aguja extendida" mostró una menor ocurrencia de pérdida accidental. Conclusiones: a pesar del costo directo promedio más alto, el uso de un "dispositivo de aguja extendida" fue más efectivo para favorecer un tiempo de acceso venoso periférico adecuado.
RESUMO Objetivos: analisar o custo direto médio e os desfechos de permanência de acesso venoso periférico, utilizando dispositivos sobre agulha com e sem extensão. Métodos: pesquisa quantitativa, exploratório-descritiva. Acompanharam-se as punções venosas e o tempo de permanência dos dispositivos. Calculou-se o custo direto médio multiplicando-se o tempo (cronometrado) despendido por profissionais de enfermagem pelo custo unitário da mão de obra, somando-se ao custo dos materiais. Resultados: o custo direto médio total do uso de dispositivo "com extensão" (US$ 9,37) foi 2,9 vezes do que o custo do uso de dispositivo "sem extensão" (US$ 4,50), destacando-se os custos dos materiais, US$ 7,71 e US$ 2,66, respectivamente. Totalizando 96 horas de permanência, o "dispositivo sobre agulha com extensão" apresentou menor ocorrência de perda acidental. Conclusões: o uso do "dispositivo sobre agulha com extensão", apesar do maior custo direto médio, foi mais eficaz para favorecer o adequado tempo de permanência do acesso venoso periférico.
Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Catheterization, Peripheral/economics , Catheterization, Peripheral/standards , Outcome Assessment, Health Care/standards , Catheterization, Peripheral/statistics & numerical data , Outcome Assessment, Health Care/statistics & numerical data , Costs and Cost Analysis , Needles/economics , Needles/standards , Needles/statistics & numerical dataABSTRACT
Based on the requirement of the ongoing healthcare reform on the performance appraisal for public hospitals, Shanghai Tenth People′s Hospital explored the performance appraisal system oriented by clinical ability and cost control from the perspective of medical administration and finance. Performance appraisal programs were made from five aspects: clinical development ability, key efficacy indicators, clinical path, disease-entity structure, cost control, aiming to highlight the functional positioning of tertiary hospitals, change doctors′ behaviors of diagnosis and treatment, lead clinical improvement and maintain healthy economy development.
ABSTRACT
This paper introduced the management of focus drugs in Ningbo, and evaluated the preliminary results by comparing the changes in terms of the income of these drugs before and after the measures taken. More measures should be taken by establishing a unified drug catalogue, strengthening the assessment, carrying prescription comment and periodic notification. The pharmacists can play a leading role in clinical rational drug use. These efforts can serve for scientific control of the unreasonable growth of medical expenses.
ABSTRACT
Objective To evaluate the impacts of DRGs payment reform on patients, medical insurance fund and hospitals, then to steadily promote the payment reform. Methods The reimbursement data of inpatients covered by NCMS yet beyond the single-disease payment were collected from two DRGs pilot hospitals from January 2016 to June 2018. Such means as descriptive statistics, t test and method of interrupted time series analysis were used to compare the changes found in the average out-of-pocket payment, actual reimbursement rate, average per-hospitalization compensation, average length of stay, and average hospitalization expense before and after the DRGs payment reform. Results After the reform, the average out-of-pocket payment and average length of stay began to fall slightly instead of the increasing trend (β3 were -72.79,-0.11, respectively, and P<0.01), the upward trend of average hospitalization expense slowed down ( β3 was -113. 55, and P<0.01), actual reimbursement rate and the average per-hospitalization compensation stayed the original growth trend (β3 were 0.10,-31.15, respectively, and P values were 0.08, 0.09, respectively). Conclusions DRGs encourages the hospitals to curb the average hospitalization expenses, with the growth trend kept at a slower pace. The payment reform does not increase the financial burden of patients, and tends to ease such pressure on funds, but the long-term effect remains to be seen.
ABSTRACT
Objective To analyze the main practices of capitation payment system reform in the case areas and put forward enlightenments and suggestions in this regard. Methods The implementation practices of the case areas were summarized, and descriptive statistical analysis was carried out on the implementation effects. Results By analyzing the effectiveness of the case areas′reform, it was found that the case areas are curbing the excessive growth of medical expenses (for example, outpatient fees per visit of Dingyuan county-level hospitals decreased from 245.11 yuan in 2015 to 218.40 yuan in 2017), increasing the actual compensation ratio of residents ( for example, the actual compensation ratio of Funan increased from 59.80% in 2015 to 63.28% in 2017), forming a medical treatment pattern within the county (for example, out-of-county compensation ratio in Dingyuan decreased from 37.38% in 2015 to 31.13% in 2017), achieving double-way referrals (for example, the number of referrals to superior hospitals of Jimo increased from 98 in 2015 to 328 in 2017), improving the subsidence of quality services, and controlling the risks of medical insurance funds. Conclusions At present, the reform of the case areas has been implemented steadily and achieved results. It is recommended to further improve such aspects as reform coordination, insurance standard setting, incentive mechanism establishment, and leadership to ensure the reform progress.
ABSTRACT
Objective To analyze the impact of canceling drug price markup policy on hospitalization expenses of urban public hospitals in Sichuan province and provide decision-making basis. Methods Data of hospitalization expenses of the top 50 diseases among inpatients discharged in 2016 and 2017 were collected, totaling 2 732 022 inpatient cases. Based on hospitalization expenses, these disease were divided into seven categories ( A-G) using dynamic clustering analysis, which represent respectively dominant diseases of different expense makeups, to compare such indicators as hospitalization expenses and composition ratios of these diseases before (2016) and after the reform (2017). Results The study found drastic changes among the medical expenses of different categories of dominant diseases. For example, per-hospitalization cost of categories E ( featuring high drug and examination expenses ) and G ( featuring balanced expenses distribution) diseases decreased since the reform, while the other categories rose instead. The proportion of drugs of different disease categories decreased to various extents. For example, category A ( high drug ratio of 5.60% ) and category E (5.15% ) diseases of which were found with the sharpest drop. Proportion of service expenses, on the other hand, rose to different extents. For example, the proportion of service expenses of all disease categories increased to varying degrees, among which category E (3.46% ), category F (3.37% ) and category D (3.36% ) accounted for the largest share of increase.Conclusions The reform is moving the cost structure of dominant diseases in Sichuan towards a rational level, yet with significant differences among disease categories. The authorities should target various categories to adjust their reimbursement policies, minimize financial burden on patients, strengthen their supervision on drug use and medical behavior, prevent such misbehaviors as the inducing demands and transferring drug markups.
ABSTRACT
ABSTRACT This theoretical and reflexive study analyzed the risks related to the maintenance of patency of the Peripherally Inserted Central Catheter with the use of saline solution in comparison with saline-filled syringes, through the application of the Healthcare Failure Mode and Effect Analysis - HFMEA. The process was mapped, detailing the failure modes of each step. For the calculation of the Risk Priority Number, the severity and probability of the failure modes were analyzed. This analysis gave rise to the severity and probability matrix. Finally, actions to reduce the failure modes in the maintenance of patency were proposed, considering the use of saline-filled syringes in comparison to the use of saline ampoules. It was verified that the use of saline ampoules is associated with a greater risk, since it requires four stages more than saline-filled syringe does not, increasing the risk of contamination and the level of three different risks, which would result in additional hospital costs. The use of the saline-filled syringe would avoid risks that could negatively affect the patient's health, the nursing professional and the health institution.
RESUMEN Este estudio teórico reflexivo analizó los riesgos relacionados con el proceso de mantenimiento de la permeabilidad del Catéter Central de Inserción Periférica, con el empleo de solución salina en comparación con jeringa rellena de solución salina, mediante la aplicación de la herramienta Healthcare Failure Mode and Effect Analysis - HFMEA. El proceso fue mapeado detallándose los modos de falla de cada etapa. Para el cómputo del Risk Priority Number, se analizaron los modos de falla en cuanto a la severidad y la probabilidad. Mediante dicho análisis, se confeccionó la matriz de severidad y probabilidad. Por fin, se evidenciaron las propuestas de acciones para la reducción de los modos de fallas en el proceso de mantenimiento de la permeabilidad en el caso de utilizarse la jeringa en comparación con la utilización de ampollas de solución salina. Se verificó que el uso de ampollas de solución salina representa mayor riesgo para el paciente, visto que demanda cuatro etapas más que el mantenimiento con jeringa rellena, aumentando el riesgo de contaminación y la criticidad de tres peligros, lo que resultaría en costos hospitalarios adicionales. El uso de la jeringa rellena evitaría riesgos mayores, los que podrían repercutir desfavorablemente en la salud del paciente, en el profesional enfermero y el centro sanitario.
RESUMO Este estudo teórico-reflexivo analisou os riscos relacionados ao processo de manutenção da permeabilidade do Cateter Central de Inserção Periférica, com o uso de solução salina em comparação com seringa preenchida com solução salina, por meio da aplicação da ferramenta Healthcare Failure Mode and Effect Analysis - HFMEA. O processo foi mapeado detalhando-se os modos de falha de cada etapa. Para o cálculo do Risk Priority Number, analisaram-se os modos de falha quanto à severidade e à probabilidade. A partir dessa análise, elaborou-se a matriz de severidade e probabilidade. Por fim, evidenciaram-se propostas de ações para redução dos modos de falhas no processo de manutenção da permeabilidade caso fosse utilizada a seringa preenchida em comparação com a utilização de ampolas de solução salina. Verificou-se que o uso de ampolas de solução salina representa maior risco para o paciente, visto que demanda quatro etapas a mais que do que a manutenção com seringa preenchida, aumentando o risco de contaminação e a criticidade de três perigos, o que resultaria em custos hospitalares adicionais. O uso da seringa preenchida evitaria riscos maiores, os quais poderiam repercutir, desfavoravelmente, na saúde do paciente, no profissional de enfermagem e na instituição de saúde.
Subject(s)
Patient Safety , Vascular Access Devices , Central Venous Catheters , Nursing Care , Quality of Health Care , Cost Control , Saline SolutionABSTRACT
Aim: Carry out a descriptive and organizational analysis of the Oral Health warehouse of the Municipal Health Department in a city in the South of Brazil in order to assist in its management. Methods: This case study is a descriptive and organizational analysis of the Oral Health warehouse of the Municipal Health Department. The Always Better Control (ABC) curve, and Vital Essential Desirable (VED) analysis and ABC-VED matrix was performed, in order to assist the warehouse's management. The first stage was a descriptive situational analysis. In the second stage, the supplies were classified by the ABC curve and the VED analysis. Subsequently, the ABC-VED matrix was carried out. Results: Changes were made together with the local manager, such as organizing the products, labeling the items in the proper places and, carrying out the inventory more frequently (monthly). Furthermore, the method the first in, first out (FIFO) was applied. Of the 120 inputs, 13% corresponded to 65% of the expenditures (class A). In class B, close to 26% of the items accounted for 25% of the expenditures. Class C accounted for 10% of the costs and 61% of total materials. In the VED analysis, 19.2% of the items were classified as vital, and 62% and 19% as essential and desirable, respectively. In ABC-VED matrix, 23.3% (72%) belonged to category I, while 63% (25.6%) and 13% (2%) were classified in categories II and III, respectively. Conclusion: The use of inventory control tools granted a better storage of products and made it easier to find the items. The ABC curve, VED analysis and ABC-VED analysis allowed greater control, considering both cost and importance of supplies
Subject(s)
Organizational Case Studies , Cost Control , Health ManagementABSTRACT
Introdução: O gerenciamento de custos em enfermagem contribui para o controle e aperfeiçoamento de medidas que permitam conhecer os custos dos procedimentos de enfermagem, além de possibilitar que esse conhecimento seja utilizado para estabelecer comparações entre o custo real desses procedimentos com o repasse financeiro coberto pelo Sistema único de Saúde (SUS), por meio da tabela única dos valores dos repasses e propor reflexões e discussões para que se adequem esses valores para o custeio dos hospitais de ensino. Objetivo: Analisar o percentual de cobertura do repasse do SUS relativo aos procedimentos de enfermagem realizados no Ambulatório de um Hospital Universitário do município de São Paulo nos anos de 2016 e 2017. Método: Trata-se de pesquisa quantitativa, exploratório-descritiva, do tipo estudo de caso único. A população foi conformada pelos procedimentos realizados no período estudado, cuja amostra para a obtenção do custo unitário constituiu-se da observação não participante de 656 procedimentos de enfermagem: consulta de enfermagem (CE); administração de medicamentos por vias intramuscular (IM), subcutânea (SC), oral (VO), sublingual (SL), instilação ocular, inalação, punção venosa para administração de medicamentos e soluções endovenosas (EV), bota de Unna (BU); curativo; retirada de pontos; cateterismo vesical de demora (CVD), cateterismo vesical de alívio (CVA); troca de sonda de cistostomia (CTT); inserção de sonda para nutrição enteral (SNE); troca do tubo de gastrostomia (GTT), troca da bolsa de colostomia, glicemia capilar e aferição de sinais vitais. O custo médio total direto (CMTD) foi calculado multiplicando-se o tempo (cronometrado) despendido pelas enfermeiras e técnicos/auxiliares de enfermagem pelo custo unitário da mão de obra direta (MOD) somando-se ao custo dos materiais e soluções. Foi utilizada a moeda brasileira real (R$). O repasse do SUS foi calculado multiplicando-se a quantidade de procedimentos pactuados pelo custo unitário repassado pelo Sistema de Gerenciamento da Tabela de Procedimentos, Medicamentos e Órtese Prótese e Materiais Especiais (OPM) do SUS (SIGTAP). Resultados: Obtiveram-se os seguintes valores dos CMTDs: R$ 30,48 (DP=26,77) para CE, R$ 6,15 (DP=1,52) para administração de medicamentos por via IM, R$ 4,46 (DP=1,05) por via SC, R$ 3,38 (DP=1,29) por VO, R$ 3,35 (DP=0,99) por via SL, R$ 4,45 (DP=2,11) para instilação ocular, R$ 4,82 (DP=1,81) para inalação, R$ 14,16 (DP=5,37) para punção venosa para administração de medicamentos e soluções EV, R$ 120,70 (DP=17,19) para BU, R$ 13,76 (DP=3,88) para curativo pequeno, R$ 25,09 (DP=9,80) para curativo médio, R$ 56,91 (DP=24,35) para curativo grande, R$ 14,91 (DP=6,40) para retirada de pontos, R$57,65 (DP=8,94) para CVD, R$ 27,12 (DP=1,93) para CVA, R$ 69,45 (DP=18,47) para troca de sonda de cistostomia, R$ 83,27 (DP=19,17) para SNE, R$ 108,74 (DP=19,49) para troca do tubo de GTT, R$ 53,65 (DP=19,47) para troca da bolsa de colostomia, R$ 6,42 (DP=1,83) para glicemia capilar e R$ 2,86 (DP=0,64) para aferição de sinais vitais. Os valores dos repasses foram de 11,13% do custo real no ano de 2016 e 16,02% no ano de 2017. Conclusão: O valor de repasse do SUS cobriu apenas 13,4% em média nos anos de 2016 e 2017, resultando em uma diferença percentual de receita significantemente inferior aos valores reais gastos pelo hospital, sendo que quanto maior a produtividade em relação à realização dos procedimentos, maior é o déficit (receita negativa) e, consequentemente, maior o gasto que não é coberto pelo repasse.
Introduction: The management of nursing costs contributes to the control and improvement of measures that allow the recognition of costs of outpatient nursing procedures, in addition to enabling this knowledge to be used to establish comparisons between the real cost of these procedures and the financial transfer done by the Unified Health System, through the use of a singular cost-coverage table and propose reflections and discussions to adjust the value of these coverages to the cost of teaching hospitals. Objective: To analyze the percentage of coverage of the Unified Health System in relation to the nursing procedures carried out in the Ambulatory of a University Hospital of the city of São Paulo in the years 2016 and 2017. Methodology: This is a quantitative, exploratory-descriptive, unique case study from which samples consisted of the non-participatory observation of 656 outpatient nursing procedures: Office Nursing (ON); the administering of medication by the means of intramuscular (IM), subcutaneous (SC), oral (VO), sublingual (SL), ocular instillation, inhalation, venous puncture for administering medication and intravenous (IV) solutions, Unna Boot (UB); therapeutics; stiches removal; urinary catheterization delay (UCD), urinary catheterization relief (UCR); cystostomy tube replacement; insertion of tube for enteral nutrition (TEN); exchange of the gastrostomy tube (EGT), exchange of the colostomy bag, capillary glycemia and vital signs gauging. The average total direct cost (ATDC) was calculated by multiplying the time (measured) spent by nurses and nursing technicians by the unit cost of direct labor (CDL), added to the cost of materials and solutions. The Brazilian Real currency (R$) was used. The coverage of the Unified Health System was calculated by multiplying the number of procedures agreed upon by the unit cost covered by the Unified Health System Table of Procedures, Medications and Orthosis Prothesis and Special Materials (OPM). Results: The following values of the ATDC were obtained: R$ 30.48 (SD=26.77) for NC, R$ 6.15 (SD=1.52) for IM, R$ 4.46 (SD=1.05) for SC, R$ 3.38 (SD=1.29) for VO, and R$ 3.35 (SD=0.99) for SL, R$ 4.45 (SD=2.11) for ocular instillation, R$ 4.82 (SD=1.81) for inhalation, R$ 14.16 (SD=5.37) for IV, R$ 120.70 (SD=17.19) for UB, R$ 13.76 (SD=3.88) for small therapeutic, R$ 25.09 (SD=9.80) for medium therapeutic, R$ 56.91 (SD=24.35) for large therapeutic, R$ 14.91 (SD=6.40) for stitches removal, R$ 57.65 (SD=8.94) for UCD, R$ 27.12 (SD=1.93) for VCR, R$ 69.45 (SD=18.47) for cystostomy, R$ 83.27 (SD=19.17) for TEN, R$ 108.74 (SD=19.49) for EGT, R$ 53.65 (SD=19.47) for exchange of the colostomy bag, R$ 6.42 (SD=1.83) for capillary glycemia and R$ 2.86 (SD=0.64) for vital signs. The value of coverage was 11.13% of the real cost in 2016 and 16.02% in 2017. Conclusion: The value covered by the Unified Health System accounted for only 13.4% on average in the years 2016 and 2017, resulting in a revenue percentage difference that is significantly lower than the actual amount spent by the hospital, and the higher the productivity in relation to the procedures, the greater the deficit (negative revenue) and, consequently, the greater the expense that is not passed on.
Subject(s)
Costs and Cost Analysis , Economics, Nursing , Unified Health System , Cost Control , Ambulatory CareABSTRACT
Introducción: La Hipertensión Arterial es el factor de riesgo más frecuente de infarto agudo de miocardio, enfermedad cerebrovascular, insuficiencia cardíaca y otras afecciones. Objetivo: Caracterizar el consumo intrahospitalario de medicamentos antihipertensivos en el Hospital Clínico Quirúrgico Manuel Fajardo en el período comprendido entre 2013 y 2017. Material y Métodos: Se realizó un estudio observacional descriptivo, de corte transversal sobre el consumo intrahospitalario de antihipertensivos. El universo estuvo determinado por todos los antihipertensivos que tuvieron indicación facultativa intrahospitalaria en los años comprendidos. Resultados: Se consumió un total de 301 616 unidades de drogas antihipertensivas. El Enalapril fue el antihipertensivo más consumido con 126 306 unidades, representando 41.89 por ciento del consumo total de antihipertensivos en el período, siendo además el más empleado en todos los años del estudio. El mayor costo lo representó el Enalapril para un total de 31 576.50 CUP. Conclusiones: Los antihipertensivos más empleados fueron el Enalapril, la Clortalidona y el Amlodipino. El Enalapril fue el más consumido en todos los años estudiados, mientras que la Clortalidona estuvo entre los tres más empleados en todos esos años. En cuanto a la repercusión económica del consumo de los antihipertensivos más empleados, el Enalapril fue el más costoso, seguido por el Amlodipino(AU)
Introduction: Arterial hypertension is the most frequent risk factor associated with acute myocardial infarction, cerebrovascular disease, heart failure, and other conditions. Objective: To characterize the intra-hospital consumption of antihypertensive drugs at Manuel Fajardo Hospital throughout the period between 2013 and 2017. Material and Methods: An observational, descriptive, cross-sectional study of the intra-hospital consumption of antihypertensive drugs was carried out. The universe was determined by all the antihypertensive drugs that had intra-hospital medical prescription during the period studied. Results: A total of 301.616 units of antihypertensive drugs were used. Enalapril was the most consumed drug with 126.306 units, representing 41.89 percent of the total consumption of antihypertensive drugs during the period; also being the most used drug for the entire years of the study. The increased cost was represented by Enalapril for a total of 31.576.50 Cuban pesos (CUP). Conclusions: The most used antihypertensive drugs were Enalapril, Chlorthalidone and Amlodipine. Enalapril was the most consumed drug in all the years studied, whereas Chlorthalidone was one of the three most commonly used. Regarding economical repercussion of the most consumed antihypertensive drugs, Enalapril was the most expensive one, followed by Amlodipine(AU)